The Fly
Mon, December 1, 2025 astatine 8:46 AM CST 4 min read
The astir talked astir and marketplace moving probe calls astir Wall Street are present successful 1 place. Here are today's probe calls that investors request to know, arsenic compiled by The Fly.
Top 5 Upgrades:
-
Goldman Sachs upgraded Chime (CHYM) to Buy from Neutral with a terms people of $27, up from $26, which offers 28% upside. The steadfast believes the marketplace is underappreciating the instrumentality complaint tailwinds from Chime's caller Chime Card.
-
BNP Paribas Exane upgraded Toast (TOST) to Outperform from Neutral with a $40 terms target. While contention successful point-ot-sale bundle for restaurants is accelerating, Toast's enactment is intact, the steadfast tells investors successful a probe note.
-
B. Riley upgraded Kratos Defense (KTOS) to Buy from Neutral with an unchanged terms people of $105. The steadfast sees a favorable risk/reward astatine existent stock levels, saying Kratos has "ample proprietary" intelligence spot "enabling an array of affordable solutions."
-
JonesResearch upgraded Spyre Therapeutics (SYRE) to Buy from Hold with a $64 terms target. Ahead of updates successful 2026, the steadfast believes the stock's risk/reward "now skews positive."
-
TD Securities upgraded New Gold (NGD) to Buy from Hold with a terms people of $12, up from $7.50. The steadfast cites the projected all-stock acquisition by Coeur Mining (CDE) for the upgrade.
Top 5 Downgrades:
-
Bernstein downgraded Zscaler (ZS) to Market Perform from Outperform with an unchanged terms people of $264. While Zscaler continues to execute well, the company's fiscal Q1 study "added communicative issues" regarding 2026 yearly recurring gross guidance, driving concerns astir accrued competition, the steadfast tells investors successful a probe note.
-
Baird downgraded Titan Machinery (TITN) to Neutral from Outperform with a terms people of $21, down from $24. The steadfast says further declines successful some the company's U.S. and Europe businesses volition unit its net and publication value.
-
Barclays downgraded Crown Castle (CCI) to Equal Weight from Overweight with a terms people of $101, down from $104. The steadfast says collecting rent from EchoStar whitethorn beryllium challenging for the operation companies.
-
Evercore ISI downgraded VICI Properties (VICI) to In Line from Outperform with a terms people of $32, down from $36. The steadfast has increasing concerns implicit the determination gaming lease with Caesars (CZR) and however a debased sum ratio gets resolved.
-
RBC Capital downgraded PTC Therapeutics (PTCT) to Sector Perform from Outperform with a terms people of $91, up from $82. With the shares rallying astir 75% successful the past 3 months, RBC's thesis has mostly played out, the steadfast tells investors successful a probe note.

39 minutes ago
1



.png)

English (CA) ·
English (US) ·
Spanish (MX) ·